Sort
82,697 grants matching “vaccine development”
University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit
$1,109,294Joseph J. Eron · Univ Of North Carolina Chapel Hill · UM1 · FY2021 · AI
Production of Pedigreed SPF Rhesus Macaques
$1,109,212Jeffrey A Roberts · University Of California At Davis · U42 · FY2019 · OD
Production of Pedigreed SPF Rhesus Macaques
$1,109,212Jeffrey A Roberts · University Of California At Davis · U42 · FY2018 · OD
Partnership to Assess Viral and Immune Landscape Intersections with ONcology for People Living with HIV (PAVILION)
$1,108,715Anna R Giuliano · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2024 · CA
Modeling Inflammation in HIV Transmission
$1,108,673Christopher Miller · University Of California At Davis · R01 · FY2014 · AI
POLYVALENT VACCINE--PHASE III TRIAL IN STAGE IV MELANOMA
$1,108,592John Wayne Cancer Institute · R01 · FY2002 · CA
Preclinical evaluation of a potent Lassa fever immunotherapeutic antibody cocktail
$1,108,530Robert F Garry · Tulane University Of Louisiana · R01 · FY2020 · AI
Molecular Basis of cDC1 Development
$1,108,321Kenneth M. Murphy · Washington University · R01 · FY2025 · AI
Crossprotective CTL Against Influenza
$1,108,246Ellis L Reinherz · Dana-Farber Cancer Inst · U01 · FY2013 · AI
Clinical Trials with Immunotoxins
$1,108,096Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
An immune-based approach for HIV eradication
$1,108,021Juan Lama · Retrovirox, Inc. · R44 · FY2015 · AI
Strategies for Cancer Immunotherapy Clinical Trials
$1,107,978Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Structural characterization of host-parasite interactions in malaria
$1,107,911Niraj Tolia · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Mechanisms of effective antibody neutralization of malaria parasites
$1,107,911Niraj Tolia · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Strategies for Cancer Immunotherapy Clinical Trials
$1,107,849Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Human Immune Monitoring Core
$1,107,746Holden T. Maecker · Stanford University · P01 · FY2022 · AI
MOLECULAR THERAPEUTICS OF RHEUMATOID ARTHRITIS
$1,107,400University Of California San Diego · P50 · FY2002 · AR
DNA Vaccine Delivery System for Biodefense with dengue
$1,107,260Alan D King · Cyto Pulse Sciences, Inc. · R44 · FY2007 · AI
Core C - in vivo Efficacy Testing (CIIG)
$1,107,241Ann E. Jerse · Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2025 · AI
Nonhuman Primate
$1,107,161Michael K Axthelm · Oregon Health & Science University · P01 · FY2015 · AI
Rapid, single-dose coronavirus vaccines via DNA-launched nanoparticles and genetic adjuvants for durable anti-coronavirus immunity
$1,107,120David B. Weiner · Wistar Institute · P01 · FY2022 · AI
DESIGN OF NOVEL IMMUNOGENS AND ADJUVANTS FOR HIV VACCINE
$1,107,109Duke University · P01 · FY2002 · AI
Assessment of metformin for restoration of immune homeostasis in HIV+ and HIV- individuals with a history of injection drug use
$1,107,091James J Kobie · University Of Alabama At Birmingham · R01 · FY2025 · DA
Complete Analysis of T cell Epitopes from Yellow Fever Virus
$1,107,075Soren Buus · University Of Copenhagen · N01 · FY2013 · AI
Rational design and targeted selection of DNA-scaffolded nicotine vaccines
$1,106,887Yung Chang · Arizona State University-Tempe Campus · R01 · FY2013 · DA